Crinetics Pharmaceuticals (CRNX)
(Real Time Quote from BATS)
$54.30 USD
+0.96 (1.80%)
Updated Jul 26, 2024 03:02 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/8/24 |
---|---|
Current Quarter | -0.86 |
EPS Last Quarter | -0.93 |
Last EPS Surprise | -10.71% |
ABR | 1.15 |
Earnings ESP
|
-1.88% |
---|---|
Current Year | -3.54 |
Next Year | -3.82 |
EPS (TTM) | -3.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.37M | 0.87M | 1.91M | 19.34M |
# of Estimates | 3 | 2 | 6 | 7 |
High Estimate | 2.50M | 1.10M | 4.01M | 60.53M |
Low Estimate | 0.60M | 0.63M | 0.60M | 3.00M |
Year ago Sales | 0.99M | 0.35M | 4.01M | 1.91M |
Year over Year Growth Est. | 37.98% | 147.14% | -52.33% | 911.08% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.86 | -0.88 | -3.54 | -3.82 |
# of Estimates | 8 | 8 | 9 | 7 |
Most Recent Consensus | -0.82 | -0.85 | -3.43 | -3.82 |
High Estimate | -0.79 | -0.83 | -3.29 | -2.94 |
Low Estimate | -0.92 | -0.96 | -3.79 | -4.86 |
Year ago EPS | -0.94 | -1.01 | -3.69 | -3.54 |
Year over Year Growth Est. | 8.51% | 12.87% | 4.07% | -7.93% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.86 | -0.88 | -3.54 | -3.82 |
7 Days Ago | -0.86 | -0.88 | -3.54 | -3.82 |
30 Days Ago | -0.86 | -0.88 | -3.53 | -3.78 |
60 Days Ago | -0.86 | -0.88 | -3.53 | -3.78 |
90 Days Ago | -0.83 | -0.86 | -3.34 | -3.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.88 | -0.96 | -3.79 | -3.75 |
Zacks Consensus Estimate | -0.86 | -0.88 | -3.54 | -3.82 |
Earnings ESP | -1.88% | -8.94% | -7.00% | 1.91% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.93 | -0.90 | -1.01 | -0.94 | NA |
Estimate | -0.84 | -0.89 | -0.89 | -0.85 | NA |
Difference | -0.09 | -0.01 | -0.12 | -0.09 | -0.08 |
Surprise | -10.71% | -1.12% | -13.48% | -10.59% | -8.98% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more